Épidémiologie des syndromes coronaires aigus en France et en Europe;Epidemiology of acute coronary syndromes in France and in Europe

Annales de Cardiologie et d'Angeiologie

Volumn 59, Issue SUPPL. 2, 2010, Pages

  Danchin, N ^a   Puymirat, E ^a   Aissaoui, N ^a   Adavane, S ^a   Durand, E ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Acute coronary syndrome; Antithrombotic medications; Epidemiology; Myocardial infarction; Myocardial reperfusion

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; EASTERN EUROPE; EUROPE; FATALITY; FRANCE; HEART ARREST; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; EUROPE; FRANCE; HUMANS; INCIDENCE;

EID: 78651353557     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/S0003-3928(10)70008-1     Document Type: Article

References (19)

1. Aouba A., Péquignot F., Le Toullec A., Jougla E. Les causes médicales de décès en France en 2004 et leur évolution 1980-2004. BEH 2007, 35-36:308-314.
2. Cambou J.P., Simon T., Mulak G., Bataille V., Danchin N. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007, 100(6-7):524-534.
3. Tuppin P., Neumann A., Danchin N., Weill A., Ricordeau P., de Peretti C., et al. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database. Arch Cardiovasc Dis 2009, 102(4):279-292.
4. European-Heart-Network. European Cardiovascular Disease Statistics 2008. 2009.
5. Yeh R.W., Sidney S., Chandra M., Sorel M., Selby J.V., Go A.S. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010, 362(23):2155-2165. 10.
6. Parikh N.I., Gona P., Larson M.G., Fox C.S., Benjamin E.J., Murabito J.M., et al. Long-term trends in myocardial infarction incidence and case fatality in the National Heart. Lung, and Blood Institute's Framingham Heart study. Circulation 2009, 119(9):1203-1210.
7. Myerson M., Coady S., Taylor H., Rosamond W.D., Goff D.C. ARIC Investigators. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2009, 119(4):503-514.
8. Koek H.L., Kardaun J.W., Gevers E., de Bruin A., Reitsma J.B., Grobbee D.E., et al. Acute myocardial infarction incidence and hospital mortality: routinely collected national data versus linkage of national registers. Eur J Epidemiol 2007, 22(11):755-762.
9. Danchin N., Vaur L., Genes N., Renault M., Ferrières J., Etienne S., et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997, 30(7):1598-1605.
10. Hanania G., Cambou J.P., Gueret P., Vaur L., Blanchard D., Lablanche J.M., et al. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 2004, 90(12):1404-1410.
11. Danchin N., Blanchard D., Steg P.G., Sauval P., Hanania G., Goldstein P., et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004, 110(14):1909-1915.
12. Danchin N., Coste P., Ferrieres J., Steg P.G., Cottin Y., Blanchard D., et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008, 118(3):268-276.
13. Danchin N., Vaur L., Genes N., Etienne S., Angioï M., Ferrières J., et al. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": oneyear results from a nationwide French survey. Circulation 1999, 99(20):2639-2644.
14. Fox K.A., Steg P.G., Eagle K.A., Goodman S.G., Anderson F.A., Granger C.B., et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007, 297(17):1892-1900.
15. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345(7):494-502.
16. Mehran R., Lansky A.J., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009, 374(9696):1149-1159.
17. Chan M.Y., Sun J.L., Newby L.K., Shaw L.K., Lin M., Peterson E.D., et al. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 2009, 119(24):3110-3117.
18. Fox K.A., Carruthers K.F., Dunbar D.R., Graham C., Manning J.R., De Raedt H., et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J Aug 2010, 30.
19. Tuppin P., Neumann A., Simon D., Weill A., de Peretti C., Danchin N., et al. Characteristics and management of diabetic patients hospitalized for myocardial infarction in France. Diabetes Metab 2010, 36(2):129-136.